| Term 
 
        | What kind of tissue is blood? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are some features of blood? |  | Definition 
 
        | Oxygenated blood is scarlet pH of 7.4
 Used for distribution, regulation, and protection
 |  | 
        |  | 
        
        | Term 
 
        | What is the ratio of intracellular fluid to extracellular? How much blood is in the body?
 |  | Definition 
 
        | ~28L intracellular fluid ~14L extracellular fluid
 ~5L of blood
 |  | 
        |  | 
        
        | Term 
 
        | What are the different layers of the blood? |  | Definition 
 
        | 55% - plasma 1% - buffy coat/white cells
 45% RBCs
 |  | 
        |  | 
        
        | Term 
 
        | What are the components of plasma? |  | Definition 
 
        | 90% water 8% protein
 other minerals, hormones, etc
 |  | 
        |  | 
        
        | Term 
 
        | What are the components of the protein layer of plasma? |  | Definition 
 
        | 60% Albumin - exert osmotic pressure, important as a carrier and in pH 36% Globulins - gamma globulins are immune (Y monomers). IgM in the circulation - pentamer. Heavy chain + light chain, Fac + Fc to bind antigen and complement
 |  | 
        |  | 
        
        | Term 
 
        | What is the difference between humoral and cellular immunity? |  | Definition 
 
        | Humoral - involves antibodies such as IgG Cellular - Only T cells involved
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Development of blood cells starting with a pleuripotent stem cell --> myeloid or lymphoid cell |  | 
        |  | 
        
        | Term 
 
        | What are the functions of red blood cells? |  | Definition 
 
        | - transport hemoglobin/oxygen - transport hemoglobin/CO2
 - Possess CA to transform CO2 into bicarbonate
 - Possess hemoglobin as a buffer
 |  | 
        |  | 
        
        | Term 
 
        | Where are red blood cells produced? |  | Definition 
 
        | At an early age, in the axial skeleton AND in the tibia/femur, after 25 only in the axial skeleton The head of bones contains spongy red bone marrow
 |  | 
        |  | 
        
        | Term 
 
        | At what point is an RBC committed? |  | Definition 
 
        | When a hemocytoblast --> proerythroblast. Reticulocytes are last stage before mature erythrocytes/RBCs, which have no DNA/nucleus
 |  | 
        |  | 
        
        | Term 
 
        | What is the role of erythropoietin? |  | Definition 
 
        | If there is a decrease in oxygen from hypoxia or an increase in oxygen demand --> HIF-1 in the kidney induced release of EPO --> red bone marrow produces RBC |  | 
        |  | 
        
        | Term 
 
        | What is the size and shape of an RBC and hemoglobin? What is their life span? |  | Definition 
 
        | A concave cell with no nucleus that is 2 micrometers wide and 7.5 micrometers long. Life span of ~120 days! Hemoglobin has 2 alpha and 2 beta polypeptide chains, 4 iron molecules which bind oxygen
 |  | 
        |  | 
        
        | Term 
 
        | What is the origin of bilirubin and how is it excreted? |  | Definition 
 
        | Dead/fragile/old RBCs are broken down into bilirubin by the liver --> secreted into small intestines and converted to urobilinogen. IF it is reabsorbed into the kidney, converted to urobilin and colors urine. If not, excreted as oxidized Sterobilin and colors feces. |  | 
        |  | 
        
        | Term 
 
        | What are the characteristics and examples of anemia? |  | Definition 
 
        | - Low hematocrit and RBCs. Hemolytic, aplastic, pernicious (B12) anemia - From abnormal hemoglobin:
 - sickle cell anemia (hemoglobin has a genetic defect in the beta chain b/c of a one amino acid substitution, forms crystals in low oxygen and clog blood vessels)
 - thalassemias	(body does not make proper amount of hemoglobin)
 |  | 
        |  | 
        
        | Term 
 
        | What are the characteristics and examples of polycythemia? |  | Definition 
 
        | - excess of RBCs that increases hematocrit and blood viscosity - Primary - cancer
 - Secondary - decreased oxygen due to altitude, hypoxia, etc
 |  | 
        |  | 
        
        | Term 
 
        | What causes Aldomet Hemolytic Anemia? |  | Definition 
 
        | 2 kinds: phagocytosis or hemolytic Aldomet binds to RBC, IgG binds to abnormal RBC and activation of the complement system, C1 binds --> C3b binds
 - in phagocytosis, C3b allows opsonization by PMN/neutrophil
 - in Hemolysis, after C3b, rest of complement is activated through C9 and hemolysis occurs. Much rarer
 |  | 
        |  | 
        
        | Term 
 
        | What are the symptoms and causes of sickle cell anemia? |  | Definition 
 
        | In the presence of low oxygen, due to deficient beta chains, cells sickle and block vessels, causing anemia and pain, possible stroke, vision problems, swollen hands and feet. |  | 
        |  | 
        
        | Term 
 
        | What are the 2 subtypes of leukocytes? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the types of granular leukocytes? What is their life span? |  | Definition 
 
        | Basophils - in tissue, also called mast cells. allergic rxns Neutrophils - greatest %, also called PMN
 Eosinophils - cause asthma
 All are end cells, do not undergo division. Life span 6-9 days
 |  | 
        |  | 
        
        | Term 
 
        | What are the types of agranular leukocytes? What are their life spans? |  | Definition 
 
        | - lymphocytes - divide into NK cells (cellular), and T/B cells (Humoral) for immune rxns. Last hours-years - Monocytes/macrophages - phagocytosis, cellular immunity, present antigens to T cell. Last months
 |  | 
        |  | 
        
        | Term 
 
        | What is the primary cell in the formation of leukocytes? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the 2 different types of stem cells in leukocytes? |  | Definition 
 
        | - Myeloid line - forms granular cells AND monocytes -Lymphoid line - forms only lymphocytes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Step before mature granular leukocytes, have a curved nucleus that is not lobed. An infection causes more band cells |  | 
        |  | 
        
        | Term 
 
        | What are the signs of short and long term inflammation? |  | Definition 
 
        | - Acute - Heat, redness, swelling, pain. Caused by neutrophils - Chronic - Loss of function, caused by macrophages
 |  | 
        |  | 
        
        | Term 
 
        | What is Neupogen and Neulasta? |  | Definition 
 
        | Neupogen stimulates the growth and proliferation of neutrophils. Attachment to PEG (Neulasta) gives a longer half life, improved solubility, and decreased immunogenicity |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Have a 10 day lifespan, bud off from megakaryocytes. Pinched off cytoplasm. Also called thrombocytes |  | 
        |  | 
        
        | Term 
 
        | What is the only prostaglandin produced by the platelet? |  | Definition 
 
        | Thromboxane (TxA2) - constricts blood vessels and aggregates platelets |  | 
        |  | 
        
        | Term 
 
        | What is the function of actin and myosin filament in the platelet? The golgi/ER? |  | Definition 
 
        | Enhanced secretion of material/granule Golgi - synthesis/storage of calcium, production of prostaglandins
 |  | 
        |  | 
        
        | Term 
 
        | What granules are associated with platelets? |  | Definition 
 
        | Dense granules - ADP, serotonin, calcium Alpha - vWF, fibrinogen, factors 5/13 (stabilize clots)
 |  | 
        |  | 
        
        | Term 
 
        | What is the difference between a clot and a thrombus? |  | Definition 
 
        | A clot is formed in response to an injury to maintain hemostasis, mass of platelets and fibrin A thrombus forms intravascularly and impedes blood flow, normally when a fibrous cap on a plaque ruptures. More platelets in arterial clots and more fibrin in venous clots.
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Maintaining blood in a fluid state as well as prevention of hemorrhage. There are 4 phases which occur simultaneously |  | 
        |  | 
        
        | Term 
 
        | What are the 4 stages of hemostasis? |  | Definition 
 
        | 1)Response to injury - vasoconstrictors such as TxA2, 5-HT, endothelin decrease blood flow (raise critical closing pressure) 2) Platelet plug stops capillary bleeding
 3) coagulation/clot formation
 4) repair and dissolution of the clot.
 |  | 
        |  | 
        
        | Term 
 
        | What are the 4 steps in the formation of a platelet plug? |  | Definition 
 
        | - Adhesion - when an area is injured, exposing fibrinogen and vWF, platelets adhere. - Activation - platelet changes shape, adhesion irreversible
 - Release reaction
 - Aggregation
 |  | 
        |  | 
        
        | Term 
 
        | What 3 receptors on the platelet surface are always expressed, and what do those receptors bind? |  | Definition 
 
        | - Gp1b9 - binds vWF bound to injured tissue, most common receptor - Gp1a2a - binds collagen exposed by injury
 -  gp1c2a - binds fibronectin/laminin (adhesion molecules) of injured tissue
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | When Gp1b9 binds to vWF, Gp2b3a is expressed and can aggregate more platelets by binding more vWF or fibrinogen |  | 
        |  | 
        
        | Term 
 
        | What is the RGD recognition site? |  | Definition 
 
        | On gp2b3a, recognizes a 3 AA sequence on vWF or fibrinogen (mostly). |  | 
        |  | 
        
        | Term 
 
        | Once platelets become activated, what 3 events lead to aggregation? |  | Definition 
 
        | 1) PL exposed --> Phospholipase A2 is activated --> conversion of Arachidonic acid into TxA2 using COX1 and thromboxane synthase (only enzyme in platelet) 2) release of granules by actin/myosin - ADP
 3) activation of Gp2b3a
 |  | 
        |  | 
        
        | Term 
 
        | Overall, how does activation proceed to aggregation in platelets? |  | Definition 
 
        | vWF (gp1b9), collagen (gp1a2a) or Thrombin (PAR) either increase phospholipase C (PLC) OR decrease adenylyl cyclace (AC). Either one increases calcium --> platelet changes shape, expression of gp2b3a, and release of granules |  | 
        |  | 
        
        | Term 
 
        | What is the difference between thromboxane formation and prostacyclin formation? |  | Definition 
 
        | Thromboxane synthase is found only in platelets, makes thromboxane out of pgH2 --> constriction and aggregation Prostacyclin synthase is found in the endothelium, converts PgH2 to prostacyclin --> vasodilation/anticoagulation
 |  | 
        |  | 
        
        | Term 
 
        | What is the release reaction? |  | Definition 
 
        | After Calcium increase and gp2b3a expression, myosin and actin release substances from granules including ADP. ADP binds to the P2Y12 receptor --> irreversible aggregation and more thromboxane |  | 
        |  | 
        
        | Term 
 
        | What mediators express gp2b3a and it's binding to fibrinogen, and what are their receptors? |  | Definition 
 
        | - ADP - P2Y12 - see a decrease in cAMP and increase in calcium just like other mediators - vWF - gp1b9 or (less) gp2b3a
 - Collagen - gp1a2a
 - Thrombin - PAR1
 - Thromboxane
 - PAF
 |  | 
        |  | 
        
        | Term 
 
        | Which factors are vitamin K dependent? |  | Definition 
 
        | Factors 2, 7, 9, 10 as well as protein C/S |  | 
        |  | 
        
        | Term 
 
        | Which factors are enzymatic, and must be activated to form a fibrin clot? |  | Definition 
 
        | 2 (Prothrombin), 7, 9, 10, 11, 13, and Kallikrein |  | 
        |  | 
        
        | Term 
 
        | Where is fibrinogen mainly found? |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | What are the purposes of factors 1 and 2? |  | Definition 
 
        | Fibrinogen links platelets together for aggregation. When cleaved by thrombin (factor 2a), Fibrin forms the lattice for a stable clot. |  | 
        |  | 
        
        | Term 
 
        | Which factors are cofactors? |  | Definition 
 
        | - Factor 3 - Tissue factor released from injured tissue. First step in extrinsic pathway - Factor 5 - Component of the prothrombinase complex. Inactivated by protein C/S. Must be activated by thrombin
 - Factor 8 - in the Tenase complex, must be activated by thrombin. Inactivated by protein C/S
 |  | 
        |  | 
        
        | Term 
 
        | At which factor do the internal and external cascades meet? |  | Definition 
 
        | Factor X, site of many drugs |  | 
        |  | 
        
        | Term 
 
        | What is the 1st factor in the intrinsic pathway? |  | Definition 
 
        | Factor 12, the glass factor |  | 
        |  | 
        
        | Term 
 
        | What is the function of Factor 13? |  | Definition 
 
        | FSF acts on fibrin monomers to polymerize them, stabilizing the clot. Maintains the platelet plug. |  | 
        |  | 
        
        | Term 
 
        | How are Factors 2,7,9,and 10 synthesized? |  | Definition 
 
        | When Glutamate is carboxylated, the process oxidizes Vit K. KO reductase reduces it back to start. |  | 
        |  | 
        
        | Term 
 
        | What are the steps of the extrinsic pathway?  When is this pathway used? |  | Definition 
 
        | The normal pathway activated upon injury for formation of a clot. - Tissue factor (Factor 3) becomes exposed and combines with circulating factor 7 (K synthesized) --> activated by either thrombin (2a) or 10a. Then TF/7a can convert 10 to 10a in the presence of calcium and then tenase complex
 |  | 
        |  | 
        
        | Term 
 
        | What are the components of the tenase complex? |  | Definition 
 
        | Factor 9a (last step of the intrinsic pathway), calcium (factor 4), factor 8a (activated by thrombin, cofactor), and phospholipid |  | 
        |  | 
        
        | Term 
 
        | What are the components of the prothrombinase complex? |  | Definition 
 
        | 5a (activated by thrombin, cofactor), calcium, phospholipid |  | 
        |  | 
        
        | Term 
 
        | How is factor 12 converted to 12a in the initiation of the intrinsic pathway? |  | Definition 
 
        | Exposed collagen Formation of Kallikrein, release of BK
 Negatively charged surface exposure on the platelet
 |  | 
        |  | 
        
        | Term 
 
        | What is the intrinsic pathway? |  | Definition 
 
        | Many more steps than the extrinsic, forms a thrombus instead of a clot. Begins with factor 12, the glass factor.
 12a converts 11 --> 11a. 11a converts 9 to 9a with the presence of calcium (factor 4). 9a is a component in the tenase complex --> reduction of 10 to 10a and then prothrombin to thrombin using the prothrombinase complex
 |  | 
        |  | 
        
        | Term 
 
        | What is the purpose of Thrombin/ Factor 2a? |  | Definition 
 
        | Thrombin Cleaves fibrinogen  into fibrin monomers. Thrombin also reduces factor 13 (FSF) with calcium to 13a, and 13 polymerizes fibrin, stabilizing a clot. |  | 
        |  | 
        
        | Term 
 
        | What is fibrinolysis and what processes are involved in it and anticoagulation? |  | Definition 
 
        | Fibronolysis is clot dissolution. 1) Plasminogen - converted to plasmin by t-PA (high affinity for fibrin)
 2) Antithrombin 3 - anticoagulation, important w/ heparin. Inhibits Xa
 3) Protein C/S - clot lysis and anticoagulation
 4) TFPI - anticoagulation
 Antiplasmin inhibits plasmin directly while PAI inhibits t-PA
 |  | 
        |  | 
        
        | Term 
 
        | What is the difference between fibrinolysis and fibrinogenolysis? |  | Definition 
 
        | - Fibrinogen is circulating. If unbound plasminogen in the plasma is converted to plasmin by t-PA/urokinase/factor 12, it will break up circulating fibrinogen which causes bleeding - Fibrin is bound to the clot. Plasminogen bound to fibrin is converted to plasmin, and splits up fibrin on the clot --> dissolving the clot.
 |  | 
        |  | 
        
        | Term 
 
        | What is the difference between Glu-plasminogen and Lys-plasminogen? |  | Definition 
 
        | Lys-plasminogen has a greater affinity for the clot - If Lys-Plasminogen is bound to a clot, t-PA QUICKLY binds to it, conversion to plasmin, and dissolution of the clot
 - Glu-plasminogen circulates, and t-PA can slowly bind to it. Circulating plasmin is inhibited by antiplasmin, and t-PA inhibited by PAI --> control of systemic bleeding
 |  | 
        |  | 
        
        | Term 
 
        | What triad of factors is the optimum for fibrinolysis? |  | Definition 
 
        | Plasminogen, t-PA, and fibrin Plasminogen binds to fibrin on a clot, t-PA converts to plasmin, breakdown of fibrin.
 |  | 
        |  | 
        
        | Term 
 
        | What is thrombin? How does thrombin promote clot formation? |  | Definition 
 
        | Factor 2a, produced by 10a. Cleaves fibrinogen into fibrin, allowing a clot to form. Activates 13, stabilizing fibrin.
 Activates cofactors 5 and 8, factor 11 in the intrinsic cascade.
 Release of ADP and vWF - increase presentation of gp2b3a and activation of platelets.
 Activates TAFI - inhibits plasminogen from binding to fibrin
 |  | 
        |  | 
        
        | Term 
 
        | How does thrombin inhibit clot formation? |  | Definition 
 
        | Activation of protein C Inhibits active cofactors 5a and 8a
 |  | 
        |  | 
        
        | Term 
 
        | What is the role of protein C, and how does it function? |  | Definition 
 
        | Thrombomodulin changes the structure of thrombin. Changed thrombin activates Protein C --> Protein C/S complex binds to platelet --> inhibits cofactors 5a and 8a, releases tPA, and inhibits PAI --> fibrinolysis. |  | 
        |  | 
        
        | Term 
 
        | What is the difference between TAFI and TFPI? |  | Definition 
 
        | TAFI - Inhibits plasminogen and therefore fibrinolysis. Clot remains TFPI - binds Xa --> TFPI/Xa complex blocks TF. Blocks extrinsic pathway --> Anticoagulation
 |  | 
        |  |